Accessory Pathway Research Articles

Registro español de ablación con catéter. XXIII informe oficial de la Asociación del Ritmo Cardiaco de la Sociedad Española de Cardiología (2023)

Introduction and objectivesWe report the results of the 2023 Spanish catheter ablation registry. MethodsProcedural data were collected and incorporated into the REDCap platform by all participating centers through a specific form. ResultsThere were 104 participating centers in 2023 compared with 103 in 2022. In 2023, the total number of ablation procedures was 26 207, indicating a stabilization of the increase observed in 2022 following the pandemic. The increase was mainly due to procedures for atrial fibrillation (AF), with a total of 9942 ablations, representing 38% of all substrates. Notably, pulse-field ablation represented 10.3% of all AF ablation procedures, leading single-shot ablation strategies to outnumber point-by-point AF ablation for the first time in the history of the registry. Cavotricuspid isthmus ablation remained the second most targeted substrate (19% of all substrates, n=5067). The overall acute success rate remained high (97%), with a downward trend in the complication rate (1.6% vs 1.8% in 2022) and mortality rate (0.03%; n=7). Compared with 2022, there was a significant increase in procedures performed using electro-anatomical mapping and zero-fluoroscopy techniques for cavotricuspid isthmus ablation (52% vs 26%), AV node re-entrant tachycardia (48% vs 34%), and accessory pathways (62% vs 22%). We registered 466 ablations in pediatric patients. ConclusionsThe data indicate a stabilization in the post-pandemic increase in ablation procedures, with an absolute and relative increase in AF as the predominant substrate. Success rates remained stable with a modest reduction in complication and mortality rates.

Wolff-Parkinson-White Syndrome in the Preterm Neonate.

Wolff-Parkinson-White (WPW) syndrome is a rare cardiac condition arising from abnormal embryologic development of the annulus fibrosus in combination with the cardiac conduction system. The abnormality results in the development of accessory pathways and preexcitation changes which can provoke episodes of tachyarrhythmias. The most common presentation of WPW syndrome is supraventricular tachycardia. Beyond customary abortive therapy, chronic management strategies vary based upon timing and clinical severity of the initial disease presentation. Prompt diagnosis and rate control have a dramatic impact on the outcomes of morbidity and mortality. The purpose of this article is to present a case study of a preterm infant who manifested with WPW syndrome. Additionally, the article will explore the pathophysiology of WPW syndrome and the timing and presentation of common clinical manifestations of the disease, along with current diagnostic and treatment strategies to achieve optimal patient outcomes in the neonatal population.

The nightmare of catheter ablation in a young male with incessant supraventricular tachycardia.

A case report involving incessant multi-types of supraventricular tachycardia and acute decompensated heart failure required a rescuing electrophysiology study and ablation. Ventricular fibrillation occurred due to coronary spasm, complicating the deteriorating heart. However, aggressive therapies, including extracorporeal support and the timely elimination of the culprit accessory pathway, successfully resolved the patient's condition.

Comparison between Remotely Supported Nurse-led Electro-Anatomic Mapping and Standard Onsite Engineer Support for Electrophysiological Procedures.

Catheter ablations of complex cardiac arrhythmias are currently guided by electro-anatomic mapping systems. The aim of this study was to compare two different approaches: remotely supported nurse-led electro-anatomic mapping with standard onsite engineer support. In this retrospective observational study, 166 patients with complex and non-complex procedures were included. 82 patients benefited from electro-anatomic mapping with remotely supported nurse-led mapping (mean age: 62±16years), while the approach for 84 patients was with standard onsite engineer support (mean age: 56±19 years). Procedural characteristics, acute results and complication rates were compared between both groups and showed similar results.Complex and non-complex procedures were conducted in both groups, including left atrial and ventricular procedures. As ventricular tachycardia and accessory pathway ablations were more frequently conducted with standard onsite engineer support, we separately analyzed the largest subgroup, 105 patients with atrial fibrillation, left atrial flutter and left atrial tachycardia. Patients in this subgroup had comparable baseline characteristics, procedure times and procedural success. Nevertheless, there were longer ablation times and more utilization of fluoroscopy in the onsite group, most likely due to more complex procedures. Our results underline the practicality of remotely supported nurse-led electro-anatomic mapping. The latter approach proved to be a safe alternative to onsite engineer support. Due to its advantages, particularly for insular settings, it will likely play a greater role in the future.

Rare Variant in MRC2 Associated With Familial Supraventricular Tachycardia and Wolff-Parkinson-White Syndrome.

Accessory pathways are a common cause of supraventricular tachycardia (SVT) and can lead to sudden cardiac death in otherwise healthy children and adults when associated with Wolff-Parkinson-White syndrome. The goal of this study was to identify genetic variants within a large family with structurally normal hearts affected by SVT and Wolff-Parkinson-White syndrome and determine causality of the gene deficit in a corresponding mouse model. Whole exome sequencing performed on 2 distant members of a 3-generation family in which multiple members were affected by SVT or Wolff-Parkinson-White pattern (preexcitation) on ECG identified MRC2 as a candidate gene. Serial electrocardiograms, intracardiac electrophysiology studies, echocardiography, optical mapping studies, and histology were performed on both Mrc2 mutant and WT (wild-type) mice. A rare HET (heterozygous) missense variant c.2969A>G;p.Glu990Gly (E990G) in MRC2 was identified as the leading candidate gene variant segregating with the cardiac phenotype following an autosomal-dominant Mendelian trait segregation pattern with variable expressivity. In vivo electrophysiology studies revealed reentrant SVT in E990G mice. Optical mapping studies in E990G mice demonstrated abnormal retrograde conduction, suggesting the presence of an accessory pathway. Histological analysis of E990G mouse hearts showed a disordered ECM (extracellular matrix) in the annulus fibrosus. Finally, Mrc2 knockdown in human cardiac fibroblasts enhanced accelerated cell migration. This study identified a rare nonsynonymous variant in the MRC2 gene in individuals with familial reentrant SVT, Wolff-Parkinson-White ECG pattern, and structurally normal hearts. Furthermore, Mrc2 knock-in mice revealed an increased incidence of reentrant SVT and bypass tract formation in the setting of preserved cardiac structure and function.

Accuracy of Different Surface Electrocardiogram Algorithms for Localization of Accessory Pathway in Comparison to Invasive Electrophysiological Localization: An Observational Study

Introduction: Detection of accessory pathway (AP) on surface ECG in sinus rhythm helps in the diagnosis of Wolff-Parkinson-White Syndrome (WPW Syndrome), Catheter ablation of AP was indicated in symptomatic patients with preexcitation. Pre-ablation AP localization inferred from the 12-lead surface electrocardiogram (ECG) facilitates a tailored ablation strategy; there by specific risk can be properly assessed. As they are based on pre-excitation in the basal state, available algorithms can lead to complex and ambiguous analysis, mostly due to the variable influence of the AP over QRS morphology. Though various algorithms on surface ECG are available to predict the site of AP on surface ECG, but none of them are accurate. So, we have compared the accuracy of different algorithms in predicting the AP localization in comparison to electrophysiological study (EPS) diagnosis. Methodology: This retrospective observational study cohort consisted of 100 consecutive patients above 15 years of age presented to the tertiary care center with the history of palpitations or for assessment of a manifest AP. Accessory pathways were identified according to the site where successful radiofrequency energy was applied. Arruda algorithm, Milstein algorithm, Fitzpatrick algorithm and Pambrun algorithm were applied on a sinus rhythm manifest preexcited ECG to predict the AP localization by two independent investigators who are unaware of site of successful catheter ablation. Then those were compared with the EPS localization to test the accuracy of individual algorithm. Then Cohen’s Kappa was run to determine if there was agreement between any of the four different algorithms with EPS using SPSS version 20.0. Results: In the study population of 100 patients, male to female ratio of study population was 1.6:1, with a mean age of presentation 43.86 ± 11.4 years with the most common age group of 31 to 45 year. when the AP locations were categorized based on EP Study 56 percent of the AP were found on the left side while 43 percent of the AP were found on right side, 77 percent of the AP were septal pathways. Among the leftsided pathways, left anteroseptal constitutes majority followed by left posteroseptal pathway. On right side majority were in right posteroseptal location in our study. Based on 4 surface ECG algorithms AP was localized and each algorithm was compared with invasive EPS localization for accuracy using Cohen’s Kappa agreement analysis. As per agreement analysis the kappa value for Milstein, Pambrun algorithm, Fitzpatrik and Arruda were 0.188, 0.343, 0.441, and 0.645 respectively. It was found that Arruda algorithm had moderate strength of agreement with the findings of EPS (κ = 0.645). This is the proportion of agreement over and above chance agreement and which was statistically significant and the strongest among all the four algorithms. Conclusion: Our study has compared the accuracy of 4 surface ECG algorithms in predicting the accessory pathway localization with the EPS; it has demonstrated that the Arruda algorithm is more precise and accurate among the available algorithms followed by Fitzpatrik, Pambrun algorithm and Milstein algorithm, Knowing the pathway prior to ablation allows for optimal procedure preparation, mapping pathways that are difficult to find and finally may lessen the catheter-related injury and shortens the procedural time.

Ventricular pre-excitation in an elderly cat

An 18-year-old female neutered Domestic Shorthair cat was referred for investigation of seizure-like episodes. Physical and neurological examination were unremarkable, as were systemic arterial blood pressure, cardiac troponin I, complete blood count and biochemistry profile. Diagnostic tests included transthoracic echocardiography which ruled out any structural cardiomyopathy, and electrocardiography which showed an underlying regular wide QRS-complex rhythm with pronounced shortening of the PR interval. Considering the findings, a diagnosis of suspected ventricular pre-excitation secondary to an accessory pathway was made. Further investigations were declined and, as no periods of tachycardia were seen on the five-minute electrocardiogram, no antiarrhythmic treatment was started.

Fasciculoventricular accessory pathway masked extensive atrioventricular conduction system disease in a patient with PRKAG2 syndrome

Fasciculoventricular accessory pathway masked extensive atrioventricular conduction system disease in a patient with PRKAG2 syndrome

Is this an anteroseptal accessory pathway?

The ECG of a patient during sinus rhythm shows preexcited QRS pattern, with rS pattern in lead V1, transition in lead V2, and positive inferior leads. Following the stepwise algorithms, the location of accessory pathway (AP) was identified at anteroseptal region. However, the precordial transition in lead V2 indicates mid-septal or posteroseptal AP. The mismatch suggested multiple APs and 5 APs were identified by electrophysiologic study. This case highlights the importance of detailed analysis of ECG in order to achieve adequate ablation.

Comparison between cryotherapy and radiofrequency energy sources for parahisian accessory pathway percutaneous ablation.

Catheter ablation of parahisian accessory pathways (PHAP) are challenging due to their proximity to the normal conduction system. Retrospective studies suggest that cryoablation has a better safety profile but a higher recurrence rate when compared to radiofrequency ablation (RFCA). The objective of this study was to compare the results of parahisian AP ablation performed by electrophysiologists with experience in both technologies. Prospective single-center, non-blinded and 1:1 model was used. Patients included had parahisian AP confirmed by an electrophysiological study and referred for radiofrequency or cryotherapy ablation according to current guidelines, under fluoroscopic guidance. No electroanatomic mapping was used. A total of 30 patients (mean age of 25±9.4 years; 90% male) were enrolled between Oct/2018 to Feb/2020. Acute success rate between RFCA and CRYO were similar (93% vs. 87%, p = 0.54). A nonsignificant reduction in short-term recurrence rate for RFCA (14% vs. 30%, p = 0.3) and mechanical trauma (6% vs. 20%; p = 0.28) was observed. Long-term recurrence rate and event-free survival time were similar in both groups after 1-year follow-up (p = 0.286). No persistent complete AV block or conduction disturbance was also observed. Considering the limitation of a small sample size and the lack of use of electroanatomic mapping for RFCA, the efficacy and safety profile of parahisian AP ablation with RFCA was not different from CRYO, when performed by experienced electrophysiologists. No cases of permanent complete AV block were reported with either energy modalities.

Effects of accessory pathway catheter ablation on left ventricular function in patients with dyssynchrony-induced cardiomyopathy associated with pre-excitation syndrome

Aim. To evaluate the effect of radiofrequency ablation (RFA) of accessory pathways on left ventricle (LV) function in patients with Wolff-Parkinson-White (WPW) syndrome and preexitation-induced dyssynchrony cardiomyopathy.Methods. The study included 22 patients with registered preexitation on the ECG and signs of dyssynchronous cardiomyopathy according to echocardiography (Echo): asynchronous movement of interventricular septum, ejection fraction (EF) decrease and/or global longitudinal strain of the left ventricle (GLS LV), heart chamber increase. The average age of patients at the time of RFA of the accessory pathways - 11 years [8;14].Results. A regular normalization of the QRS complex width was observed after RFA (p = 0.0002). To assess reverse LV remodeling, all patients underwent Echo on day 3 after RFA. In patients with an initially reduced LVEF, its increase was noted. In patients with initial dilatation and an increase in LV volume, normalization of these indicators was noted. However, dynamics of LVEF and its volume was not statistically significant in the early postoperative period. According to Speckle-tracking Echo during medical check-up, complete normalization of longitudinal deformation was observed in 13 patients (59%), this indicator improvement - in 7 patients (31.8%). The average GLS LV before RFA was -17.25 [-16.4; -19], after RFA - -21.5 [-19; -24] (p = 0.0001).Conclusion. Reverse remodeling and restoration of LV function after RFA of accessory pathways indicates a cause- and-effect relationship between the accessory pathways functioning and dyssynchronous cardiomyopathy development. Therefore, patients with signs of preexitation-induced dyssynchronous cardiomyopathy are indicated for RFA of accessory pathways, regardless of age and tachycardia paroxysms.

Meta-Analysis of Genome-Wide Association Studies Reveals Genetic Mechanisms of Supraventricular Arrhythmias.

Substantial data support a heritable basis for supraventricular tachycardias, but the genetic determinants and molecular mechanisms of these arrhythmias are poorly understood. We sought to identify genetic loci associated with atrioventricular nodal reentrant tachycardia (AVNRT) and atrioventricular accessory pathways or atrioventricular reciprocating tachycardia (AVAPs/AVRT). We performed multiancestry meta-analyses of genome-wide association studies to identify genetic loci for AVNRT (4 studies) and AVAP/AVRT (7 studies). We assessed evidence supporting the potential causal effects of candidate genes by analyzing relations between associated variants and cardiac gene expression, performing transcriptome-wide analyses, and examining prior genome-wide association studies. Analyses comprised 2384 AVNRT cases and 106 489 referents, and 2811 AVAP/AVRT cases and 1,483 093 referents. We identified 2 significant loci for AVNRT, which implicate NKX2-5 and TTN as disease susceptibility genes. A transcriptome-wide association analysis supported an association between reduced predicted cardiac expression of NKX2-5 and AVNRT. We identified 3 significant loci for AVAP/AVRT, which implicate SCN5A, SCN10A, and TTN/CCDC141. Variant associations at several loci have been previously reported for cardiac phenotypes, including atrial fibrillation, stroke, Brugada syndrome, and electrocardiographic intervals. Our findings highlight gene regions associated with ion channel function (AVAP/AVRT), as well as cardiac development and the sarcomere (AVAP/AVRT and AVNRT) as important potential effectors of supraventricular tachycardia susceptibility.

Efficacy and safety of pulsed field ablation for accessory pathways: a pilot study.

Radiofrequency ablation is used as a first-line therapy for accessory pathways (APs). However, data regarding the effects of pulsed field ablation (PFA) on APs are limited. We sought to evaluate the acute procedural and 6-month success and safety of PFA in a cohort of patients with APs. A focal contact force-sensing PFA catheter was used for patients with APs. Pulsed field ablation generator generated a bipolar and biphasic waveform (±1000 V) with a duration of 100 ms from the tip of the PFA catheter. A 100% acute procedural success was achieved in 10 conscious patients with APs (7 left anterolateral, 2 left inferolateral, and 1 right posteroseptal APs) including 6 (60%) patients after an initial application. The average total ablation time was 6.3 ± 4.9 s for 4.7 ± 1.8 ablation sites (ASs), including 3.1 ± 2.4 s at targets and 3.2 ± 2.9 s at 3.2 ± 2 bolus ASs. The mean skin-to-skin time was 59.3 ± 15.5 min, and PFA catheter dwell time was 29.4 ± 7.8 min. One patient encountered transient sinus arrest during PFA due to parasympathetic overexcitation. Sinus rhythm was restored in all patients without any significant adverse events during the short-term follow-up. Pulsed field ablation of APs was feasible, effective, and safe. Its efficiency was remarkable for its ultrarapid termination of AP conduction. Further studies are warranted to prove whether utilization of PFA with current parameters can extend to manifold AP ablation.

Evaluating the efficacy of pre-ablation algorithms in WPW syndrome localization: a retrospective study

Abstract Background and Objective Wolf-Parkinson-White (WPW) syndrome is a congenital condition that can be diagnosed at any age and may lead to dysrhythmias, most notably atrioventricular reentrant tachycardia (AVRT). Ablation of the accessory pathway responsible for the disorder has become a standard treatment approach. The success of ablation therapy is closely linked to accurately localizing the accessory pathway. Consequently, algorithms have been developed to predict the location of the accessory pathway using pre-ablation electrocardiography (ECG) parameters. This study aims to evaluate the predictive values of previously published algorithms. Method This study included 122 patients diagnosed with WPW syndrome who underwent successful ablation of a manifest accessory pathway at our university's cardiac electrophysiology laboratory between 2019 and 2023. We retrospectively examined these patients' baseline characteristics and their procedures' features. Additionally, a team analyzed their baseline electrocardiograms (ECGs) using the EASY-WPW, Pambrun, and St. George algorithms. The sensitivity, specificity, PPV, and NPV of these algorithms were then calculated based on the location of the accessory pathways identified during the patients’ ablation treatments. Results The median age of the patients in this study was 33 years (18 - 79). Among them, 65 patients (53.3%) were male (Table 1). Ablation treatment was conducted using a 3D mapping system for all included patients, considering only those who achieved acute procedural success for analysis. The most frequently observed accessory pathway localization was the posteroseptal region of the tricuspid annulus, found in 48 patients (39.3%). Regarding the accuracy of accessory pathway prediction, the EASY-WPW, Pambrun, and St. George algorithms demonstrated correct localization rates of 81%, 72%, and 62%, respectively. The efficacy of these predictions varied according to the specific localization of the accessory pathways (Table 2). Conclusion This study highlights the limitations of previously published algorithms in predicting the localization of accessory pathways in WPW syndrome. The notably lower success rates observed in our research, as compared to earlier studies, might be attributed to variations in how localization is defined across studies, differences in the interpretation of these algorithms by users, or evolving definitions of localization resulting from advancements in 3-dimensional mapping systems. Given these findings, there is a clear need for the development of new algorithms that incorporate current localization definitions and are validated in larger patient cohorts.

Differential right apical and left basal pacing: a new maneuver that rules out the presence of a left accessory pathway with retrograde conduction

Abstract Background Differential apex-base pacing or entrainment is a very useful maneuver in patients with concealed septal accessory pathways. This study evaluates for the first time the diagnostic value of differential right apical pacing (aRV) and basal left ventricular pacing (bLV) in patients with left accessory pathways before and after ablation. Purpose To determine the value of differential aRV and bLV pacing as a simple maneuver to assess the successful ablation of left accessory pathways. Methods Successive patients with preexcitation or concealed left accessory pathways were prospectively included. Baseline pre-ablation (PRE) 1:1 retrograde conduction was evaluated by the S-A interval during pacing at the aRV (PREaRV) and at the bLV (PREbLV) measured to the earliest atrial electrogram detected by a decapolar catheter placed in the coronary sinus. The S-A interval resulting from direct atrial capture during high outputpacing at the bLV at (PREdir) was also measured. The same S-A intervals, pacing at the same locations and measured to the same dipole in the coronary sinus were reassessed after ablation (POSaRV, POSbLV, POSdir) in order to compare the total values and their differences. Results 47 patients were included (age 31 yo [range 4 – 76 yo], 70% male sex, transeptal approach used in 62%). Ablation of the accessory pathway was successful in all patients. 5 patients could not be analyzed due to absence of 1:1 retrograde conduction before ablation, 27/43 (63%) patients had 1:1 retrograde nodal conduction after ablation. A significant prolongation of the S-A intervals were observed after ablation during pacing at the aRV (POSaRV – PREaRV = 43±38 ms, IC95% 27-59 ms, p<0,001) and from the bLV (POSbVI – PREbVI = 126±53 ms, IC95% 105-147 ms, p<0,001). As expected, the S-A interval during direct atrial capture from the bLV did not prolong (POSdir – PREdir = 2±10 ms, IC95% -2 – 6 ms, p=0,41). The difference PREaRV – PREbLV before ablation (difPRE) was 80±26 ms (IC95% 72-88 ms) and never overlapped with the difference POSaRV – POSbLV after ablation (-6 ±33 ms, IC95% -19 – 8 ms) (difPOS) except in one case of left posteroseptal accessory pathway. The δ value (difPRE – difPOS) was 83±40 ms (IC95% 67-100 ms, p<0,001). A difPOS value <20 ms discriminated all successful ablations of non posteroseptal accesory pathways. Conclusion The S-A values obtained during differential RV apical and LV basal pacing before and after ablation are valid to discriminate the efficacy of the procedure. The POSaVD – POSbVI value is always <20 ms after successful ablation and excludes retrograde conduction over any left non-posteroseptal accesory pathway. This same value is ≤0 ms in 72% of cases of successful ablation.Figure.

Tackling of challenging accessory pathways utilizing open window mapping, does it add benefit?

Abstract Introduction 3D electroanatomical mapping is beneficial in accessory pathway ablation for better delineation of the anatomy, less procedure and fluro time, it depends on point-by-point mapping to identify the connection sites of the accessory pathway (AP) to the atria or ventricle, or the site of the AP potential. However, this approach requires an accurate interpretation of the local electrograms. In contrast, open window mapping (OWM) doesn’t need to differentiate the signals site of origin, it is based on an automatic annotation process in which the signals with the highest -dV/dt are annotated at each obtained point irrespective of the cardiac chamber. (1) Few reports describe the additional benefit of such technique in patients with complex congenital heart diseases. (2) Purpose To present our centre experience in using OWM technique in addition to early meets late (EML) algorism in accessory pathway ablation especially in patients with complex congenital heart disease or previous failed ablation trials. Methods We reviewed patients who underwent AVRT ablation at our centre from August 2022 to August 2023 with emphasis on cases mapped using OWM & EML techniques using high density mapping catheters. Demographic data, clinical presentation, resting & tachycardia ECGs, and Echo reports were examined thoroughly, additionally, we revised the 3D maps, ablation details, fluro dose, and outcomes of the procedures. Results Over one year, among 74 patients underwent AVRT ablation, open window mapping was used in 4 patients with manifest preexcitation (Rt posteroseptal in 3 of them & Rt free wall in one patient). Among the four patients: 3 were pediatrics, youngest was 5 years old, 19 Kg, 2 patients had previous failed ablation trials, their Echo reports revealed severe form of Ebstein anomaly with large ASD in the first patient, case 2 had single ventricle physiology with bidirectional Glenn while the two other patients had structurally normal heart (Table). The mapping using the OW & EML techniques confirmed the site of AP breakthrough conduction at Rt posteroseptal area in 3 of them and Rt posterolateral area in the remaining one, ablation resulted in immediate loss of preexcitation with no recurrence in all patients. Average fluro dose was 0.1 Gy which is significantly lower than the average dose in the remaining AVRT cases. Over median follow up period of 9 months, there were no recurrence of the accessory pathways & no complications. Conclusion Open window mapping technique is highly beneficial for accurate & fast mapping of accessory pathways especially in those with complex congenital heart where AP ablation remains considerably more challenging. OWM also added benefit in redo cases as the previous ablation trials hampered manual EGM interpretation. Finally, most of our cases were pediatrics where using high density mapping catheters and contact force ablation catheters appears to be safe and effective.Demographic, ECG, Echo & procedure data3D map & Echo in patient 2

Implementation of near zero fluoroscopy in supraventricular tachycardia ablation procedures: a single center experience

Abstract Background Supraventricular tachycardia (SVT) are common cardiac arrhythmias, and catheter ablation has proven to be a very effective treatment, but exposes patients and healthcare providers to radiation. "Near Zero Fluoroscopy" (NZF) techniques, utilizing advanced imaging, aim to reduce radiation exposure while maintaining efficacy. Purpose To present an analysis of near-zero fluoroscopy in SVT ablation procedures, in a tertiary center, since its implementation. Methods We prospectively enrolled 446 SVT-diagnosed patients for this study. All of them underwent NZF procedures using the same specific 3D mapping system, between January/19 and December/22. Patients with atrial fibrillation or macroreentrant atrial tachycardias or when a different mapping system was used, were excluded. All patients provided informed consent. Results Our population had 266 (60%) females and a median age of 39 (IQR 24-51) years. AVNRT was the most frequent arrhythmia documented (229 cases, 51%), followed by Accessory Pathways (AP) (201 cases, 45%) and focal atrial tachycardia (AT) (16 cases, 4%). The ablation success rate was high (405/418, 97%). There was no ablation attempt in 12 patients (9 APs and 3 ATs) and the unsuccessful ablations (7/418 cases, 1,67%) were APs. Overall, fluoroscopy time was 1.1 minutes (IQR 0-2.6). There was no statistically significant difference in the distribution of fluoroscopy time among the types of SVT based on the Kruskal-Wallis test (p 0.14). Observing trends of fluoroscopy use through time, we acknowledge the presence of a learning curve, leading towards shorter times of X-ray during procedures along the first 3 years of implementation of a near-zero strategy. Median times (IQR) of fluoroscopy were as follows: 2019 – 2.25 (0.45-3.4) min; 2020 – 1 (0-2.5) min; 2021 – 0 (0-1.9) min; 2022 – 0.55 (03.05) min. (see BoxPlot) Pairwise comparisons using the Wilcoxon rank-sum test with continuity correction revealed statistically significant differences in medians between all pairs of years, with p-values adjusted for multiple comparisons using the Bonferroni method (p<0.01). In 2022, fluoroscopy time increased, when compared to 2021. We believe this finding can be explained by the fact that in 2022, our department received a new fellow and a young EP consultant (coming from a center where NZF was not the standard for SVT ablation), both being in the lab on a daily basis, explaining this upward trend in fluoroscopy time. There were no acute complications requiring hospital admission or active treatment. Conclusion Our results emphasize the potential of near-zero fluoroscopy techniques to enhance safety and reduce radiation exposure while maintaining a high level of procedural efficacy in the treatment of SVT cases. Absence of acute complications highlighted the safety of these approaches.

Ablation of anomalous mitral annular pathways via transradial access: early hospital discharge due to the covid-19 pandemic

Abstract Introduction Wolff-Parkinson-White (WPW) syndrome arises from the conduction through accessory pathways (AP) connecting the atria and ventricles, bypassing the atrioventricular node. Radiofrequency catheter ablation of AP is the recommended treatment, often performed via transradial access. This approach is widely utilized in percutaneous coronary intervention due to its safety, effectiveness, patient preference, cost-effectiveness, and simplicity. Our study aims to present the results of AP ablation in the mitral annulus through transradial access amid the Covid-19 pandemic, marked by hospital bed scarcity and the need for early discharge. Materials and Methods Between May 2020 and December 2021, eight cases of transradial AP ablation in the mitral annulus were conducted. The service had previously achieved success in 16 transradial ablation cases. Among the eight cases during the pandemic, 62.5% were male, aged 24 to 56 years, all experiencing tachycardic palpitations and pre-syncope with a history of hospitalization. In 25% of cases, syncope episodes occurred. Patients were on propafenone, with no structural heart disease. Covid-19 tests were negative. Radial and ulnar artery perfusion integrity was assessed using the Allen maneuver and arterial Doppler. The right radial artery was used in 100% of cases. Sixty-two point five percent of accessory pathways were in anterolateral positions, and 37.5% were left posteroseptal. The approach was through the right radial artery, under local anesthesia, with venous sedation, using a 7Fr introducer sheath and positioning of the explorer catheter. Mapping was conducted during sinus rhythm, and adenosine IV tests followed ablation. The catheter was removed, and a pneumatic local dressing was applied for 2 hours, followed by a conventional dressing change for 24 hours. Results Ablation was successful in all eight patients. The procedure time ranged from 40 to 80 minutes, with an average of 55 minutes. Two to four radiofrequency applications were applied for a total of 2 minutes, using 55 W energy and a temperature of 55 to 60°C. No complications occurred during or after the procedure. Patients were discharged three hours post-intervention. Follow-up included reviews every four months, ECGs without ventricular pre-excitation, asymptomatic patients without antiarrhythmic medication, and no complications at the puncture site one year post-procedure. Conclusion Although based on a small sample of eight cases, and acknowledging the need for a larger sample to establish the procedure as an alternative, considering possible operator experience influence, we conclude that radial access proved effective and safe in this patient group. Its usage was exceptional, specifically in the context of a pandemic with crowded hospitals. Selection criteria and comparisons with other alternatives should be adopted for analyzing its potential future use.Transradial approachAblation catheter in the mitral plane

Trans-catheter cryoablation of parahisian accessory pathways: a single centre experience

Abstract Introduction Transcatheter radiofrequency (RF) ablation of perinodal accessory pathways (parahisian/midseptal APs) is still challenging especially in young patients due to a high risk for inadvertent atrioventricular block (AVB) requiring permanent pacing. Recently, cryo-ablation (CA) has evolved as an RF alternative, thanks to a safer profile and a better catheter stability. Purpose To evaluate the safety, efficacy and outcomes of CA in patients with parahisian/midseptal APs. Methods 73 pts undergoing a first ablation of septal APs at our institution were retrospectively analyzed. Among these, we selected 20 patients with a diagnosis of para-hisian/midseptal AP confirmed by EP study (EPS) and 3D-electro-anatomic mapping (EAM), ablated using cryoenergy. Before delivering CA, a cryomapping (CM) at the target AP site was performed at −30°C using a 6- mm-tip catheter. Successful CM was defined as: (1) loss of delta wave in case of manifest pre-excitation, (2) termination of a sustained AVRT, (3) retrograde conduction block through the AP during ventricular pacing in case of concealed AP. CA was initiated following successful CM, at a temperature of −75°C for 300 s with an additional "bonus" CA application (300s). Acute procedural endpoint was permanent complete abolition of AP conduction; long-term clinical endpoint was defined as no recurrence of delta wave or AVRT on serial ECG monitoring at follow-up (1, 6, 12 months). RESULTS Baseline characteristics are summarized in Fig. 1. Fifty-five % were pediatric patients, only 3/20 presented a structural HD. Up to 90% of the patients experienced a symptomatic AVRT, while delta-wave was present at baseline ECG in 19/20 patients. EPS combined with 3D-EAM showed a para-hisian AP in 80% and a mid-septal AP in 20%. Mean distance between His bundle electrogram and AP site was 5.72 mm (4-6.8 mm, Fig. 2). Orthodromic AVRT was induced in all the 20 pts. Maen procedural and fluoroscopy times were, respectively, 103.4 ± 26.4 and 3.15± 1.76 min . Acute success was achieved in 20/20 patients (100%) with AP block of conduction obtained within few seconds (<10s) after a mean CM number of 3.3 ± 1.2 (Fig. 2). Two patients developed transient 2:1 AV block and 1 patient transient RBBB during CM, with immediate recovery within 20s from CM termination. No peri-procedural complications or permanent AV block were observed. One patient had an early AP re-conduction (6 hours later) and was successfully re-ablated the following day. During a mean FU of 361 ± 34 days, only two patients (10%) experienced an AVRT recurrence and underwent a second successful CA. Conclusions Cryoablation of parahisian and midseptal APs is a safe and effective alternative to RF, resulting in a low risk of recurrence over 12-months-follow-up with no incidence of permanent AV block. A near-zero fluoroscopy approach combining CA and 3D-EAM is feasible and should be considered especially in very young patients with parahisian APs.Fig. 1Fig. 2

Feasibility of catheter ablation with zero-fluoroscopy in congenital heart disease

Abstract Background Catheter ablation (CA) with zero and near-zero fluoroscopy has been shown to be safe and effective in patients (pts) without structural heart disease, but there are limited data regarding CA in congenital heart disease (CHD). Aim Our aim was to compare the safety and outcome of zero-fluoroscopy (ZF) and fluoroscopy (non-ZF) CA of CHD pts. Methods This is a single-center retrospective study of CHD pts who underwent CA at our center between 2006-2020. The ZF and non-ZF groups were compared for the complexity of anatomy, arrhythmia substrate, difficulties of vascular access, transseptal or transbaffle puncture, intracardiac pacemaker/ICD, procedural parameters, complications, and acute outcome. Near-ZF CAs (effective dose ≤1 mSv) were assigned to the ZF group. Results The ZF group included 22 pts (age: 22±13 years) and the non-ZF group 48 pts (age: 31±12 years). The distribution of CHD anatomical complexity (mild/moderate/severe) was 18.2%-68.2%-13.6% in the ZF group and 14.6%-68.7%-16.7% in the non-ZF group. Arrhythmia diagnoses were focal atrial tachycardia (ZF: 4.6%), atrial flutter (ZF: 45.4%, non-ZF: 75.0%), atrioventricular reentry tachycardia (AVRT) via manifest accessory pathway (AP) (ZF: 31.8%, non-ZF: 10.4%), AVRT via concealed AP (ZF: 4.6%, non-ZF: 8.3%), and atrioventricular nodal reentry tachycardia (ZF: 13.6%, non-ZF: 6.3%). Difficulties in vascular access occurred in 4.5% of the ZF group and 18.8% of the non-ZF group (p=0.10). The rate of transseptal/transbaffle puncture was significantly higher in the non-ZF group (22.9% vs. 4.6%, p=0.04). In the ZF group 13.6% and in the non-ZF group 20.8% of pts had pacemaker or ICD (p=0.22). Electroanatomical mapping was used in all CAs in both groups. There was no significant difference in procedure time, ablation time and the number of radiofrequency applications (ZF group: 169±53 min, 1205±906 sec, 28±15 vs. non-ZF group: 203±74 min, 1459±940 sec, 34±16, p>0.05). The acute success rate was 100% in both groups. No complications occurred in any group. Conclusion Zero fluoroscopic CA was feasible in 1/3 of the pts with CHD and as safe and effective as fluoroscopic ablation. No significant differences were found in the non-fluroscopy related procedural data between the two groups.